| Literature DB >> 18302729 |
Ingrid B de Groot1, Marein M Favejee, Max Reijman, Jan A N Verhaar, Caroline B Terwee.
Abstract
BACKGROUND: The Knee Injury and Osteoarthritis Outcome Score (KOOS) was constructed in Sweden. This questionnaire has proved to be valid for several orthopedic interventions of the knee. It has been formally translated and validated in several languages, but not yet in Dutch. The purpose of the present study was to evaluate the clinimetric properties of the Dutch version of the KOOS questionnaire in knee patients with various stages of osteoarthritis (OA).Entities:
Mesh:
Year: 2008 PMID: 18302729 PMCID: PMC2289810 DOI: 10.1186/1477-7525-6-16
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
Characteristics of the five patient groups
| 36 (27–50) | 56 (27–72) | 65 (42–81) | 61(42–78) | 77 (36–89) | |
| 22 | 32 | 52 | 51 | 78 | |
| 0.7 (0.0–6.7) | 3.9 (0.0–10.0) | 6.1 (1.0–10.0) | 1 (0.0–9.4) | 5.0 (0–10) | |
| 85.3 | 62.9 | 41.8 | 70.1 | 61.6 | |
| 78.6 | 63.2 | 46.4 | 72.3 | 64.7 | |
| 91.2 | 69.3 | 43.4 | 72.8 | 56.6 | |
| 71.0 | 36.2 | 29.1 | 33.2 | 26.8 | |
| 67.0 | 44.6 | 30.9 | 52.2 | 36.6 | |
| 84.7 | 63.6 | 34.6 | 70.7 | 55.4 | |
| 86.4 | 61.1 | 34.9 | 61.7 | 32.9 | |
| 92.4 | 82.8 | 61.7 | 81.8 | 64.1 | |
| 77.8 | 64.8 | 26.6 | 57.4 | 31.0 | |
| 91.7 | 87.4 | 57.4 | 69.7 | 59.9 | |
| 86.8 | 79.6 | 69.1 | 74.6 | 70.3 | |
| 75.4 | 68.9 | 53.9 | 66.5 | 55.5 | |
| 84.0 | 65.0 | 60.2 | 66.8 | 51.4 |
Results are presented as median (range) or mean ± SD. Abbreviations: OA; osteoarthritis, TKA; total knee arthroplasty, Revision of TKA; Revision of total knee arthroplasty; VAS, Visual Analogue Scale; BP, bodily pain; PF, physical function; SF, social function; RF, role limitations because of physical problems; RE, role limitations because of emotional problems; MH, mental health; VT, vitality; GH, general health perception; ADL, Activities of daily living; QoL, Quality of life.
Internal consistency of the KOOS subscales, expressed by Cronbach's alpha
| 0.94 | 0.93 | 0.80 | 0.92 | 0.87 | |
| 0.71 | 0.83 | 0.56 | 0.74 | 0.78 | |
| 0.78 | 0.97 | 0.94 | 0.94 | 0.93 | |
| 0.87 | 0.95 | 0.98 | 0.88 | 0.95 | |
| 0.81 | 0.85 | 0.73 | 0.81 | 0.90 |
Abbreviations: OA; osteoarthritis, TKA; total knee arthroplasty, Revision of TKA; Revision of total knee arthroplasty, ADL, Activities of daily living; QoL; Quality of life.
Reliability of all subscales of the KOOS
| Pain | 85.3 (18.5) | 89.7 (12.5) | -4.4 (9.4) | 7.2 | 0.80 | 0.60–0.90 | |
| Symptoms | 78.6 (7.1) | 81.3 (16.8) | -2.2 (12.8) | 9.0 | 0.74 | 0.54–0.86 | |
| ADL | 91.2 (15.1) | 93.5 (10.8) | -2.3 (7.1) | 5.2 | 0.85 | 0.71–0.92 | |
| Sport/recreation | 71.0 (23.4) | 73.0 (22.9) | -1.7 (12.8) | 9.0 | 0.85 | 0.73–0.92 | |
| QoL | 67.0 (21.6) | 69.6 (20.5) | -2.5 (10.3) | 7.4 | 0.88 | 0.77–0.94 | |
| Pain | 62.9 (25.7) | 63.2 (23.7) | 0.0 (12.9) | 9.0 | 0.87 | 0.78–0.92 | |
| Symptoms | 63.2 (24.4) | 66.2 (21.9) | -1.5 (11.3) | 8.0 | 0.87 | 0.79–0.92 | |
| ADL | 69.3 (24.2) | 69.2 (23.7) | 0.6 (8.2) | 5.8 | 0.94 | 0.90–0.97 | |
| Sport/recreation | 36.2 (32.0) | 39.7 (32.5) | -4.8 (15.9) | 11.6 | 0.87 | 0.78–0.92 | |
| QoL | 44.6 (26.3) | 47.3 (25.4) | -2.1 (10.3) | 7.4 | 0.91 | 0.86–0.95 | |
| Pain | 61.6 (23.4) | 63.9 (21.9) | -2.3 (14.3) | 10.1 | 0.80 | 0.67–0.88 | |
| Symptoms | 64.7 (21.5) | 62.9 (21.7) | 1.7 (10.2) | 7.2 | 0.89 | 0.81–0.94 | |
| ADL | 56.6 (21.9) | 59.5 (22.9) | -2.9 (16.4) | 11.7 | 0.73 | 0.56–0.83 | |
| Sport/recreation | 26.8 (34.1) | 27.4 (34.2) | -2.2 (35.1) | 24.6 | 0.45 | 0.19–0.66 | |
| QoL | 36.6 (26.6) | 40.3 (27.5) | -3.7 (14.9) | 10.8 | 0.84 | 0.73–0.91 | |
Abbreviations: OA; osteoarthritis, SD, standard deviation; SEM, standard error of measurement; ICC agreement, intraclass correlation coefficient for agreement; CI, confidence interval. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. Revision of TKA; Revision of total knee arthroplasty, AD; Activities of daily living; QoL; Quality of life.
Validity of the KOOS for the patient group with mild OA
| BP | 0.44 | 0.41 | 0.38 | ||
| PF | 0.53 | 0.46 | 0.56 | ||
| SF | 0.23 | 0.13 | 0.25 | 0.09 | 0.26 |
| RF | 0.28 | 0.37 | 0.35 | 0.36 | 0.40 |
| RE | 0.31 | 0.24 | 0.19 | 0.25 | 0.24 |
| MH | 0.42 | 0.20 | 0.42 | 0.30 | 0.38 |
| VT | 0.42 | 0.27 | 0.37 | 0.34 | 0.31 |
| GH | |||||
Validity is expressed by Spearman correlations between KOOS subscales, SF-36 subscales and VAS-pain. Abbreviations: OA; osteoarthritis, BP, bodily pain; PF, physical function; SF, social function; RF, role limitations because of physical problems; RE, role limitations because of emotional problems; MH, mental health; VT, vitality; GH, general health perception; ADL, Activities of daily living; QoL, Quality of life. In bold: convergente correlations that should be ≥ 0.60, In Italic: divergente correlations that should be ≤ 0.30. All other hypotheses are expected to be between 0.30 and 0.60. Correlations marked by * have to be 0.05 higher than the other convergent correlations.
Validity of the KOOS for the patient group with moderate OA
| BP | 0.57 | 0.43 | 0.62 | ||
| PF | 0.60 | 0.60 | 0.70 | ||
| SF | 0.36 | 0.48 | 0.50 | 0.05 | 0.42 |
| RF | 0.23 | 0.32 | 0.36 | 0.12 | 0.26 |
| RE | 0.33 | 0.39 | 0.41 | 0.16 | 0.46 |
| MH | 0.23 | 0.36 | 0.27 | -0.01 | 0.25 |
| VT | 0.37 | 0.35 | 0.48 | 0.05 | 0.37 |
| GH | |||||
Validity is expressed by Spearman correlations between KOOS subscales, SF-36 subscales and VAS-pain. Abbreviations: OA; osteoarthritis, BP, bodily pain; PF, physical function; SF, social function; RF, role limitations because of physical problems; RE, role limitations because of emotional problems; MH, mental health; VT, vitality; GH, general health perception; ADL, Activities of daily living; QoL, Quality of life. In bold: convergente correlations that should be ≥ 0.60, In Italic: divergente correlations that should be ≤ 0.30. All other hypotheses are expected to be between 0.30 and 0.60. Correlations marked by * have to be 0.05 higher than the other convergent correlations.
Validity of the KOOS for the patient group with severe OA
| BP | 0.55 | 0.37 | 0.47 | ||
| PF | 0.27 | 0.12 | 0.22 | ||
| SF | 0.36 | 0.42 | 0.33 | 0.12 | 0.49 |
| RF | 0.28 | 0.21 | 0.37 | 0.04 | 0.32 |
| RE | 0.13 | 0.18 | 0.28 | -0.04 | 0.25 |
| MH | 0.11 | 0.12 | 0.36 | -0.07 | 0.18 |
| VT | 0.26 | 0.24 | 0.46 | 0.10 | 0.29 |
| GH | |||||
Validity is expressed by Spearman correlations between KOOS subscales, SF-36 subscales and VAS-pain. Abbreviations: OA; osteoarthritis, BP, bodily pain; PF, physical function; SF, social function; RF, role limitations because of physical problems; RE, role limitations because of emotional problems; MH, mental health; VT, vitality; GH, general health perception, ADL; Activities of daily living, QoL; Quality of life. In bold: convergente correlations that should be ≥ 0.60, In Italic: divergente correlations that should be ≤ 0.30. All other hypotheses are expected to be between 0.30 and 0.60. Correlations marked by * have to be 0.05 higher than the other convergent correlations.
Validity of the KOOS for the patient group with a primary TKA
| BP | 0.58 | 0.48 | 0.62 | ||
| PF | 0.56 | 0.67 | 0.64 | ||
| SF | 0.39 | 0.35 | 0.48 | 0.26 | 0.51 |
| RF | 0.53 | 0.53 | 0.68 | 0.57 | 0.49 |
| RE | 0.22 | 0.27 | 0.39 | 0.37 | 0.23 |
| MH | 0.46 | 0.46 | 0.52 | 0.37 | 0.52 |
| VT | 0.61 | 0.48 | 0.52 | 0.31 | 0.49 |
| GH | |||||
Validity is expressed by Spearman correlations between KOOS subscales, SF-36 subscales and VAS-pain. Abbreviations: OA; osteoarthritis, BP, bodily pain; PF, physical function; SF, social function; RF, role limitations because of physical problems; RE, role limitations because of emotional problems; MH, mental health; VT, vitality; GH, general health perception; ADL, Activities of daily living; QoL, Quality of life. In bold: convergente correlations that should be ≥ 0.60, In Italic: divergente correlations that should be ≤ 0.30. All other hypotheses are expected to be between 0.30 and 0.60. Correlations marked by * have to be 0.05 higher than the other convergent correlations.
Validity of the KOOS for the patient group with a revision of the TKA
| BP | 0.39 | 0.30 | 0.54 | ||
| PF | 0.20 | 0.32 | 0.36 | ||
| SF | 0.20 | 0.11 | 0.24 | 0.16 | 0.42 |
| RF | 0.12 | 0.18 | 0.14 | 0.24 | 0.26 |
| RE | 0.10 | 0.09 | 0.00 | -0.01 | 0.15 |
| MH | 0.15 | 0.26 | 0.21 | 0.05 | 0.28 |
| VT | 0.15 | 0.28 | 0.18 | 0.05 | 0.39 |
| GH | |||||
Validity is expressed by Spearman correlations between KOOS subscales, SF-36 subscales and VAS-pain. Abbreviations: OA; osteoarthritis, BP, bodily pain; PF, physical function; SF, social function; RF, role limitations because of physical problems; RE, role limitations because of emotional problems; MH, mental health; VT, vitality; GH, general health perception; ADL, Activities of daily living; QoL, Quality of life. In bold: convergente correlations that should be ≥ 0.60, In Italic: divergente correlations that should be ≤ 0.30. All other hypotheses are expected to be between 0.30 and 0.60. Correlations marked by * have to be 0.05 higher than the other convergent correlations.
Percentage ceiling/floor effects of the KOOS (best possible score/worst possible score)
| 14/0 | 11/0 | ||||
| 13/2 | 3/0 | 8/0 | 10/11 | 5/2 | |
| 0/2 | 0/2 | 0/0 | 0/ | ||
| 10/0 | 3/0 | 7/0 | 0/7 | 6/3 | |
| 2/0 | 4/0 | 2/0 | 6/ | 4/4 |
Abbreviations: OA; osteoarthritis, Revision of TKA, Revision of total knee arthroplasty; ADL, Activities of daily living; QoL, Quality of life.